"Without question, BioAdvance funding was a critical ingredient for the launch of Melior Discovery. There was simply no comparable funding source for a startup entity such as ours. Melior would not exist today, would not have discovered a new class of candidate diabetes therapeutics, and would not have uncovered new clinical candidates for our pharma partners were it not for funding conduit provided by BioAdvance."

Andrew Reaume
President & CEO
Melior Discovery, Inc.
Exton, PA